Oregon Bioscience Association
The Sept. 15-17 event will feature internationally known guest speakers from
companies such as 23andme, the Fogarty Institute for Innovation, Translational Genomic Institute, Lawrence Livermore National Laboratories and the BioDesign Institute to showcase local innovation stories, emerging translational therapy investment opportunities and national bioscience trends. Early discounted registration ends Aug. 31.
Aug 12, 2014
The Arizona Journal of Pharmacy’s Winter 2014 issue notes that across the U.S., “poor medication adherence leads to poorer health, more frequent hospitalizations, higher risk of death and costs our medical system as much as $290 billion each year.” Here in Oregon, providers, pharmacists, and patient groups are addressing this growing issue by bringing forth legislation to help all Oregon patients better manage their medications. Medicare Part D plans starting doing this in January.
Mar 4, 2014
The Arizona Journal of Pharmacy’s Winter 2014 issue notes that across the U.S., “poor medication adherence leads to poorer health, more frequent hospitalizations, higher risk of death and costs our medical system as much as $290 billion each year.” Here in Oregon, providers, pharmacists, and patient groups are addressing this growing issue by bringing forth legislation to help all Oregon patients better manage their medications. Medicare Part D plans starting doing this in January.
Feb 6, 2014
September 18, 2013 -- Well known inventor, Dr. Albert Starr, signed over this first patent, for the first model of an artificial heart valve, to his partner, James Edwards, of Edwards Laboratories. It’s part of the legacy story of Dr. Starr’s world-changing invention; a story that includes his personal ‘cherry blossom moment.’
Sep 18, 2013
October 5, 2012 -- Governor John Kitzhaber has proclaimed Tuesday, Oct.
Oct 5, 2012
September 21, 2012 -- The job description for Portland, Oregon’s next mayor is clearly economic development, at least that’s where the current two mayoral candidates, Charlie Hales and Jefferson Smith, agree. The candidates also agree in prioritizing access to capital and incentives to grow investments in the sector. However, they differ in how to make that happen.
Sep 24, 2012
July 16, 2012 -- After three years of a downward recessionary impact on the bioscience industry across the U.S., Oregon kept an overall positive pace in employment growth and wage gains in the biotechnology and life science sectors, according to the BIO/Batelle State Bioscience Industry Development 2012 Report released last week. The Oregon Bioscience Association (Oregon Bio) established the same pattern in its local economic impact review.
Jul 16, 2012